Table 2.
Sarcoidosis Subject Characteristics
| Imaging: Scadding Stage | N (%) |
|---|---|
| 0 | 9 (8.7) |
| 1 | 13 (13) |
| 2 | 49 (47) |
| 3 | 10 (10) |
| 4 | 23 (22) |
| Immunosuppression use | 56 (54) |
| Extra-thoracic involvement | 71 (69) |
| Pulmonary Function Tests | |||
|---|---|---|---|
| N | Mean (SD) | Range | |
| FVC %predicted | 96 | 94 (15) | 59 – 129 |
| FEV1 %predicted | 96 | 89 (17) | 28 – 133 |
| FEV1/FVC | 96 | 0.75 (0.092) | 0.34 – 0.99 |
| DLCO %predicted | 67 | 72 (15) | 39 – 108 |
| TLC %predicted | 63 | 94 (15) | 59 – 124 |
DLCO = Diffusing Capacity of the Lungs for Carbon Monoxide, FEV1 = Forced Expiratory Volume in 1 Second, FEV1/FVC = Forced Expiratory Volume in 1 Second to Forced Vital Capacity ratio, FVC = Forced Vital Capacity, TLC = Total Lung Capacity.